These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 8697885)
1. Candida glabrata: in vitro susceptibility of 84 isolates to eight antifungal agents. Arias A; Arévalo MP; Andreu A; Rodríguez C; Sierra A Chemotherapy; 1996; 42(2):107-11. PubMed ID: 8697885 [TBL] [Abstract][Full Text] [Related]
2. Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents. Odds FC; Webster CE; Abbott AB J Antimicrob Chemother; 1984 Aug; 14(2):105-14. PubMed ID: 6094418 [TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts. Arthington-Skaggs BA; Motley M; Warnock DW; Morrison CJ J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985 [TBL] [Abstract][Full Text] [Related]
4. In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata. Defontaine A; Bouchara JP; Declerk P; Planchenault C; Chabasse D; Hallet JN J Med Microbiol; 1999 Jul; 48(7):663-670. PubMed ID: 10403417 [TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis. Carrillo-Muñoz AJ; Guglietta A; Palacín C; Casals J; del Valle O; Guardià C; Rodríguez V; Quindós G Chemotherapy; 2004 Dec; 50(6):308-13. PubMed ID: 15608448 [TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole. Martín E; Parras P; Lozano MC Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508 [TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of oral Candida to seven antifungal agents. Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594 [TBL] [Abstract][Full Text] [Related]
8. [Torulopsis glabrata. Morphologic characteristics, biotyping and sensitivity to isolates of antifungal agents in vitro]. Pospisil J Cesk Epidemiol Mikrobiol Imunol; 1991 Jan; 40(1):43-8. PubMed ID: 1826472 [TBL] [Abstract][Full Text] [Related]
9. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
10. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin]. Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765 [TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents. Choukri F; Benderdouche M; Sednaoui P J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913 [TBL] [Abstract][Full Text] [Related]
12. Reduced Antifungal Susceptibility of Vulvovaginal Candida Species at Normal Vaginal pH Levels: Clinical Implications. Spitzer M; Wiederhold NP J Low Genit Tract Dis; 2018 Apr; 22(2):152-158. PubMed ID: 29474241 [TBL] [Abstract][Full Text] [Related]
13. Systemic Candida infection in University hospital 1997-1999: the distribution of Candida biotypes and antifungal susceptibility patterns. Ng KP; Saw TL; Na SL; Soo-Hoo TS Mycopathologia; 2001; 149(3):141-6. PubMed ID: 11307597 [TBL] [Abstract][Full Text] [Related]
14. Antifungal drug resistance in pathogenic fungi. Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500 [TBL] [Abstract][Full Text] [Related]
15. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy]. Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361 [TBL] [Abstract][Full Text] [Related]
16. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses]. Uchida K; Matsuzaka A; Aoki K; Yamaguchi H Jpn J Antibiot; 1991 May; 44(5):562-70. PubMed ID: 1652654 [TBL] [Abstract][Full Text] [Related]
17. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses]. Uchida K; Hosaka J; Aoki K; Yamaguchi H Jpn J Antibiot; 1991 May; 44(5):571-9. PubMed ID: 1652655 [TBL] [Abstract][Full Text] [Related]
18. Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China. Wang FJ; Zhang D; Liu ZH; Wu WX; Bai HH; Dong HY Chin Med J (Engl); 2016 May; 129(10):1161-5. PubMed ID: 27174323 [TBL] [Abstract][Full Text] [Related]
19. [Comparative sensitivity of yeasts to antifungal agents using a standardized micromethod]. Guinet R Pathol Biol (Paris); 1986 May; 34(5):536-9. PubMed ID: 3534739 [TBL] [Abstract][Full Text] [Related]
20. In-vitro antifungal activity of sertaconazole, bifonazole, ketoconazole, and miconazole against yeasts of the Candida genus. Carrilo-Muñoz AJ; Tur C; Torres J J Antimicrob Chemother; 1996 Apr; 37(4):815-9. PubMed ID: 8722548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]